Share This Article:

Vitamin C activation of the biosynthesis of epoxyeicosatrienoic acids

Full-Text HTML Download Download as PDF (Size:1442KB) PP. 204-218
DOI: 10.4236/abb.2012.33029    4,470 Downloads   7,086 Views   Citations


The cardiovascular effects of vitamin C (VitC) could be mediated by epoxyeicosatrienoic acids (EETs). We aimed to study the mechanism of VitC-dependent microsomal formation of cis- and trans-EETs and the regulation of EET levels in rat isolated perfused kidneys and in vivo. VitC biphasically stimulated rat kidney microsomal cis- and trans-EET formation in a ratio of 1:2, involving the participation of lipid hydroperoxides (LOOHs), Fe2+ , and cytochrome P450 (CYP). Levels of LOOHs correlated with microsomal EET production. LOOH stimulation of CYP isoforms resulted in preferred trans- over cis-EET formation from arachidonic acid and was associated with the cleavage of LOOHs, which indicated a CYP peroxy-genase activity. EETs contributed to VitC-induced vasodilator responses in rat isolated perfused kidneys. VitC (1 mg/ml) given in the drinking water for 9 days doubled rat urinary EET excretion, increased plasma levels of EETs, mostly trans-EETs, by 40%, and reduced plasma levels of 20-hydroxyeicosatetraenoic acid. Depletion of VitC in brain cortex and kidney tissues by more than 20- and 50-fold, respectively, in gulonolactone oxidase-knockout mice was associated with mild increases in tissue EETs. These data suggest that LOOHs are a determinant factor for EET formation in vivo in which VitC exerts a key regulatory effect. VitC-activated CYP peroxygenase activity may represent a CYP interaction with lipoxygenases and cyclooxygenases to mediate the cardiovascular effects of VitC via formation of EETs.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Jiang, H. , Harrison, F. , Jain, K. , Benjamin, S. , May, J. , Graves, J. , Zeldin, D. , Falck, J. , Hammock, B. and McGiff, J. (2012) Vitamin C activation of the biosynthesis of epoxyeicosatrienoic acids. Advances in Bioscience and Biotechnology, 3, 204-218. doi: 10.4236/abb.2012.33029.


[1] Frei, B., England, L. and Ames, B.N. (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proceedings of the National Academy of Sciences USA, 86, 6377-6381.
[2] Block, G., Jensen, C.D., Norkus, E.P., Hudes, M. and Crawford, P.B. (2008) Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young Black and White women. Nutrition Journal, 7, 35. doi:10.1186/1475-2891-7-35
[3] Drossos, G.E., Toumpoulis, I.K., Katritsis, D.G., Ioannidis, J.P., Kontogiorgi, P., Svarna, E. and Anagnostopoulos, C.E. (2003) Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? Journal of Thoracic and Cardio-vascular Surgery, 125, 330-335. doi:10.1067/mtc.2003.3
[4] Duffy, S.J., Gokce, N., Holbrook, M., Hunter, L.M., Biegelsen, E.S., Huang, A., Keaney, J.F. Jr. and Vita, J.A. (2001) Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. American Journal of Physiology—Heart and Circulatory Physiology, 280, H528-H534.
[5] Rossig, L., Hoffmann, J., Hugel, B., Mallat, Z., Haase, A., Freyssinet, J.M., Tedgui, A., Aicher, A., Zeiher, A.M. and Dimmeler, S. (2001) Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation, 104, 2182-2187. doi:10.1161/hc4301.098284
[6] Giusti-Paiva, A. and Domingues, V.G. (2010) Centrally administered ascorbic acid induces antidiuresis, natriure- sis and neurohypo-physeal hormone release in rats. Neuro-Endocrinology Letters, 31, 87-91.
[7] Jackson, T.S., Xu, A., Vita, J.A. and Keaney, J.F. Jr. (1998) Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circulation Research, 83, 916-922.
[8] Pfister, S.L., Gauthier, K.M. and Campbell, W.B. (2010) Vascular pharmacology of epoxyeico-satrienoic acids. Advances in Pharmacology, 60, 27-59. doi:10.1016/B978-0-12-385061-4.00002-7
[9] Elmarakby, A.A. (2012) Reno-protective mechanisms of epox-yeicosatrienoic acids in cardiovascular disease. American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, 302, R321-R330.
[10] Jiang, H., Quilley, J., Doumad, A.B., Zhu, A.G., Falck, J. R., Hammock, B.D., Stier, C.T. Jr. and Carroll, M.A. (2011) Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats. American Journal of Physiology—Heart and Circulatory Physiology, 300, H1990-H1996.
[11] Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D.C. and Liao, J.K. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science, 285, 1276-1279. doi:10.1126/science.285.5431.1276
[12] Nithipatikom, K. and Gross, G.J. (2010) Review article: Epoxyeicosa-trienoic acids: Novel mediators of cardio- protection. Journal of Cardiovascular and Pharmacology and The-rapeutics, 15, 112-119. doi:10.1177/1074248409358408
[13] Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A. and Salvetti, A. (1998) Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation, 97, 2222-2229.
[14] Edwards, D.H., Chaytor, A.T., Bakker, L.M. and Griffith, T.M. (2007) Modulation of gapjunction-dependent arterial relaxation by ascorbic acid. Journal of Vascular Research, 44, 410-422. doi:10.1159/000104254
[15] Campbell, W.B. and Flem-ing, I. (2010) Epoxyeicosatrienoic acids and endothe-lium-dependent responses. Pflugers Arch—European Journal of Physiology, 459, 881-895.
[16] Popp, R., Brandes, R.P., Ott, G., Busse, R. and Fleming, I. (2002) Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Circulation Research, 90, 800-806. doi:10.1161/01.RES.0000015328.20581.D6
[17] Papoulidis, P., Ananiadou, O., Chalvatzoulis, E., Ampat- zidou, F., Koutsogiannidis, C., Karaiskos, T., Madesis, A. and Drossos, G. (2011) The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myo-cardial revascularization surgery: A single-center experience—A pilot study. Interactive Cardiovasc Thoracic Surgery, 12, 121-124.
[18] Padayatty, S.J., Katz, A., Wang, Y., Eck, P., Kwon, O., Lee, J.H., Chen, S., Corpe, C., Dutta, A., Dutta, S.K. and Levine, M. (2003) Vitamin C as an antioxidant: Evaluation of its role in disease prevention. Journal of the American College of Nutrition, 22, 18-35.
[19] Jiang, H., McGiff, J.C., Quilley, J., Sacerdoti, D., Reddy, L.M., Falck, J.R., Zhang, F., Lerea, K.M. and Wong, P.Y. (2004) Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells. The Journal of Biological Chemistry, 279, 36412-36418. doi:10.1074/jbc.M403962200
[20] Bui, P.H., Hsu, E.L. and Hankinson, O. (2009) Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Molecular Pharmacol-ogy, 76, 1044-1052. doi:10.1124/mol.109.057760
[21] McCallum, G.P., Weedon, A.C., Krug, P. and Bend, J.R. (1996) Micro-somal cytochrome P450 peroxygenase metabolism of arachidonic acid in guinea pig liver. Journal of Pharmacology and Experimental Therapeutics, 278, 1188-1194.
[22] Brash, A.R., Chang, M.S., Funk, C.D. and Song, W. (1994) Novel transformations of HPETEs by cytochrome P450s. Annals of the New York Academy of Sciences, 744, 25-30. doi:10.1111/j.1749-6632.1994.tb52720.x
[23] Joo, H., Lin, Z. and Arnold, F.H. (1999) Laboratory evo- lution of peroxide-mediated cytochrome P450 hydroxyla- tion. Nature, 399, 670-673. doi:10.1038/21395
[24] Capdevila, J., Saeki, Y. and Falck, J.R. (1984) The mecha- nistic plu-rality of cytochrome P-450 and its biological ramifications. Xenobiotica, 14, 105-118. doi:10.3109/00498258409151401
[25] Jiang, H., Zhu, A.G., Mamczur, M., Morisseau, C., Ham- mock, B.D., Falck, J.R. and McGiff, J.C. (2008) Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells. Journal of Pharmacology and Experimental Therapeutics, 326, 330-337. doi:10.1124/jpet.107.134858
[26] Sato, P.H. and Zannoni, V.G. (1976) Ascorbic acid and hepatic drug metabolism. Journal of Pharmacology and Experimental Therapeutics, 198, 295-307.
[27] Zeldin, D.C., DuBois, R.N., Falck, J.R. and Capdevila, J.H. (1995) Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Archives of Biochemistry and Biophysocs, 322, 76-86.
[28] Chen, Y.J., Jiang, H. and Quilley, J. (2003) The nitric oxide- and prostaglandin-independent component of the renal vasodilator effect of thimerosal is mediated by epoxyeicosatrienoic acids. Journal of Pharmacology and Experimental Therapeutics, 304, 1292-1298. doi:10.1124/jpet.102.042671
[29] Harrison, F.E., Yu, S.S., Van Den Bossche, K.L., Li, L., May, J.M. and McDonald, M.P. (2008) Elevated oxida- tive stress and sensorimotor deficits but normal cognition in mice that cannot synthesize ascorbic acid. Journal of Neurochemistry, 106, 1198-1208. doi:10.1111/j.1471-4159.2008.05469.x
[30] Deved, V., Poyah, P., James, M.T., Tonelli, M., Manns, B. J., Walsh, M. and Hemmelgarn, B.R. (2009) Ascorbic acid for ane-mia management in hemodialysis patients: A systematic review and meta-analysis. American Journal of Kidney Disease, 54, 1089-1097. doi:10.1053/j.ajkd.2009.06.040
[31] Bridges, K.R. and Hoffman, K.E. (1986) The effects of ascorbic acid on the intracellular metabolism of iron and ferritin. Journal of Biological Chemistry, 261, 14273-14277.
[32] Nelli, S., Craig, J. and Martin, W. (2009) Oxidation by trace Cu2+ ions underlies the ability of ascorbate to induce vascular dysfunction in the rat perfused mesentery. European Journal of Pharmacology, 614, 84-90. doi:10.1016/j.ejphar.2009.04.033
[33] Schwartzman, M.L., Davis, K.L., McGiff, J.C., Levere, R.D. and Abra-ham, N.G. (1988) Purification and characterization of cytochrome P-450-dependent arachidonic acid epoxyge-nase from human liver. Journal of Biological Chemistry, 263, 2536-2542.
[34] Rifkind, A.B., Lee, C., Chang, T.K. and Waxman, D.J. (1995) Arachidonic acid metabolism by human cyto- chrome P450s 2C8, 2C9, 2E1, and 1A2: Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver micro- somes. Archives of Biochemistry and Biophysics, 320, 380-389. doi:10.1016/0003-9861(95)90023-3
[35] Muindi, J.F. and Young, C.W. (1993) Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-transretinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 iso- forms. Cancer Research, 53, 1226-1229.
[36] Norio, K., Wikstrom, M., Salmela, K., Kyllonen, L. and Lindgren, L. (2003) Ascorbic acid against reperfusion injury in human renal transplantation. Transplant International, 16, 480-485. doi:10.1111/j.1432-2277.2003.tb00352.x
[37] Williams, M.J., Sutherland, W.H., McCormick, M.P., de Jong, S.A., McDonald, J.R. and Walker, R.J. (2001) Vitamin C improves endothelial dysfunction in renal allo- graft recipients. Nephrology Dialysis Transplantation, 16, 1251-1255. doi:10.1093/ndt/16.6.1251
[38] Yue, H., Jansen, S.A., Strauss, K.I., Borenstein, M.R., Barbe, M.F., Rossi, L.J. and Murphy, E. (2007) A liquid chromato-graphy/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosa- trienoic acids, hydroxyeicosatetraenoic acids, and ep- oxyeicosatrienoic acids in rat brain tissue. Journal of Pharmaceutical and Biomedical Analysis, 43, 1122-1134. doi:10.1016/j.jpba.2006.10.009
[39] Labeque, R. and Marnett, L.J. (1987) 10-Hydroperoxy-8, 12-octadecadienoic acid. A diagnostic probe of alkoxyl radical generation in metal-hydroperoxide reactions. Journal of the American Chemical Society, 109, 2828-2829. doi:10.1021/ja00243a048
[40] Schafer, F.Q., Qian, S.Y. and Buettner, G.R. (2000) Iron and free radical oxidations in cell membranes. Cell and Molecular Biology (Noisy-legrand), 46, 657-662.
[41] Vaz, A.D., McGinnity, D.F. and Coon, M.J. (1998) Epoxidation of olefins by cytochrome P450: Evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant. Proceedings of the National Academy of Sciences USA, 95, 3555-3560.
[42] Newcomb, M., Hollenberg, P.F. and Coon, M.J. (2003) Multiple mechanisms and multiple oxidants in P450-catalyzed hydroxylations. Archives of Biochemistry and Biophysics, 409, 72-79. doi:10.1016/S0003-9861(02)00445-9
[43] Maeda, N., Hagihara, H., Nakata, Y., Hiller, S., Wilder, J. and Red-dick, R. (2000) Aortic wall damage in mice unable to synthesize ascorbic acid. Proceedings of the National Academy of Sciences USA, 97, 841-846.
[44] do Carmo, J.M., da Silva, A.A., Morgan, J., Wang, Y.X., Munusamy, S. and Hall, J.E. (2010) Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in obese mice. Nutrition, Metabolism & Cardiovascular Diseases, in press. doi:10.1016/j.numecd.2010.10.017
[45] Yoshioka, M., Aoyama, K. and Matsushita, T. (1985) Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats (SH rats). International Journal of Vitamin and Nutrition Research, 55, 301-307.

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.